$SKIN
Beauty Health Co Stock $skin

$skin Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038926 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$96.82M	$97.41M
YoY Change	-1.34%	9.71%
Cost Of Revenue	$13.24M	$110.0M
YoY Change	-59.84%	304.03%
Gross Profit	$83.59M	-$12.55M
YoY Change	28.25%	-120.39%
Gross Profit Margin	86.33%	-12.89%
Selling, General & Admin	$61.00M	$67.71M
YoY Change	-6.05%	6.55%
% of Gross Profit	72.98%
Research & Development	$3.046M	$1.839M
YoY Change	110.65%	-15.14%
% of Gross Profit	3.64%
Depreciation & Amortization	$9.288M	$7.350M
YoY Change	-9.34%	267.32%
% of Gross Profit	11.11%
Operating Expenses	$64.05M	$69.55M
YoY Change	-7.1%	5.83%
Operating Profit	$19.54M	-$82.10M
YoY Change	-618.99%	1882.64%
Interest Expense	$6.142M	$3.445M
YoY Change	39.09%	-201.92%
% of Operating Profit	31.43%
Other Income/Expense, Net	$3.418M	$4.872M
YoY Change	76.0%	41.18%
Pretax Income	-$8.800M	-$70.34M
YoY Change	-439.38%	10094.06%
Income Tax	$603.0K	$3.500M
% Of Pretax Income
Net Earnings	-$9.403M	-$73.82M
YoY Change	-346.47%	-56449.62%
Net Earnings / Revenue	-9.71%	-75.78%
Basic Earnings Per Share		-$0.56
Diluted Earnings Per Share	-$0.07	-$0.56
COMMON SHARES
Basic Shares Outstanding	131.3M shares	132.9M shares
Diluted Shares Outstanding		132.9M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$523.0M	$559.4M
YoY Change	-7.95%	-18.24%
Cash & Equivalents	$523.0M	$559.4M
Short-Term Investments
Other Short-Term Assets	$28.88M	$35.90M
YoY Change	8.16%	64.45%
Inventory	$91.32M	$74.88M
Prepaid Expenses
Receivables	$54.70M	$66.81M
Other Receivables	$332.0K	$1.000M
Total Short-Term Assets	$698.3M	$738.0M
YoY Change	-11.51%	-17.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.35M	$29.40M
YoY Change	-22.1%	-9.23%
Goodwill	$125.8M	$124.7M
YoY Change	0.98%	1.57%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.04M	$15.54M
YoY Change	13.03%	50.41%
Total Long-Term Assets	$230.9M	$235.1M
YoY Change	5.03%	10.69%
TOTAL ASSETS
Total Short-Term Assets	$698.3M	$738.0M
Total Long-Term Assets	$230.9M	$235.1M
Total Assets	$929.1M	$973.1M
YoY Change	-7.91%	-11.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$44.77M	$35.88M
YoY Change	47.58%	10.15%
Accrued Expenses	$19.85M	$30.49M
YoY Change	30.71%	78.2%
Deferred Revenue	$450.0K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$115.0M	$125.9M
YoY Change	57.3%	64.68%
LONG-TERM LIABILITIES
Long-Term Debt	$738.4M	$737.3M
YoY Change	0.58%	0.57%
Other Long-Term Liabilities	$2.767M	$410.0K
YoY Change	-90.17%	-98.78%
Total Long-Term Liabilities	$2.767M	$410.0K
YoY Change	-99.64%	-99.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$115.0M	$125.9M
Total Long-Term Liabilities	$2.767M	$410.0K
Total Liabilities	$869.7M	$883.1M
YoY Change	3.86%	4.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$478.9M	-$469.5M
YoY Change	27.93%	24.15%
Common Stock	$12.00K	$14.00K
YoY Change	-14.29%	-6.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$59.39M	$89.96M
YoY Change
Total Liabilities & Shareholders Equity	$929.1M	$973.1M
YoY Change	-7.91%	-11.92%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$9.403M	-$73.82M
YoY Change	-346.47%	-56449.62%
Depreciation, Depletion And Amortization	$9.288M	$7.350M
YoY Change	-9.34%	267.32%
Cash From Operating Activities	-$5.170M	$17.96M
YoY Change	-4.13%	-157.2%
INVESTING ACTIVITIES
Capital Expenditures	$2.168M	$2.890M
YoY Change	-23.23%	-137.33%
Acquisitions
YoY Change
Other Investing Activities	$2.000K	-$1.540M
YoY Change
Cash From Investing Activities	-$2.168M	-$4.440M
YoY Change	-23.23%	-42.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-31.36M	-2.350M
YoY Change	-69.4%	-97.65%
NET CHANGE
Cash From Operating Activities	-5.170M	17.96M
Cash From Investing Activities	-2.168M	-4.440M
Cash From Financing Activities	-31.36M	-2.350M
Net Change In Cash	-38.70M	11.17M
YoY Change	-65.04%	-108.03%
FREE CASH FLOW
Cash From Operating Activities	-$5.170M	$17.96M
Capital Expenditures	$2.168M	$2.890M
Free Cash Flow	-$7.338M	$15.07M
YoY Change	-10.7%	-163.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	559444000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	568197000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	3445000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	3380000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7449000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7049000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-145000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	336393000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	6317000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	500000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6378000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	495000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3687000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	345406000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-81000	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	370000	usd
CY2022Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	80000000	usd
CY2022Q3	skin	Purchase Of Equity Forward Contract In Connection With Accelerated Share Repurchase PurchaseOfEquityForwardContractInConnectionWithAcceleratedShareRepurchase	20000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1636000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	250768000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	167053000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-20259000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2195000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2034000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3577000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1310000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	888000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	152408000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	3364000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	545000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	698000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8524000	usd
CY2023Q2	us-gaap	Accelerated Share Repurchase Program Adjustment AcceleratedShareRepurchaseProgramAdjustment	-2240000	usd
CY2023Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4828000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8185000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1093000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	89957000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-90713000	usd
	us-gaap	Net Income Loss NetIncomeLoss	37691000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20286000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20876000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15955000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11063000	usd
	us-gaap	Depreciation Depreciation	6996000	usd
	us-gaap	Depreciation Depreciation	5269000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	1751000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	525000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3172000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3172000	usd
	skin	Inventory Obsolesce InventoryObsolesce	18809000	usd
	skin	Inventory Obsolesce InventoryObsolesce	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	11905000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	5667000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2760000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1670000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8364000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-71521000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	8897000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6007000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3426000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16198000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50118000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	7887000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26920000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7084000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3797000	usd
	skin	Payments For Asset Acquisitions PaymentsForAssetAcquisitions	18458000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29339000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	80000000	usd
	skin	Payment For Accelerated Share Repurchase Of Equity Forward Contract PaymentForAcceleratedShareRepurchaseOfEquityForwardContract	0	usd
	skin	Payment For Accelerated Share Repurchase Of Equity Forward Contract PaymentForAcceleratedShareRepurchaseOfEquityForwardContract	20000000	usd
	skin	Payment Of Accelerated Share Repurchases PaymentOfAcceleratedShareRepurchases	2240000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2388000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2763000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-102763000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-220015000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2337000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	684208000	usd
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Inventory Write Down InventoryWriteDown	5700000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	301170000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	267743000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	301170000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	267743000	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	23793000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	38373000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	51085000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	71283000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	74878000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	109656000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	11900000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	10523000	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6973000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4154000	usd
CY2023Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	4011000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	5643000	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1719000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1357000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	20752000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21677000	usd
CY2023Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	7196000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4904000	usd
CY2023Q3	skin	Share Repurchase Liability ShareRepurchaseLiability	4828000	usd
CY2022Q4	skin	Share Repurchase Liability ShareRepurchaseLiability	0	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	4688000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2344000	usd
CY2023Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4186000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2348000	usd
CY2023Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1819000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9593000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3768000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30491000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15183000	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	18339000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	12494000	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	16062000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	18184000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	146674000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	82032000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	64642000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	114806000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	68420000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46386000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20286000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20876000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	124593000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	86000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	124679000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2400000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1900000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3500000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-800000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.049
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.026
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.910
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.047
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	400000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	usd
CY2023Q3	skin	Proceeds From Employee Retention Credit Received ProceedsFromEmployeeRetentionCreditReceived	5400000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8185000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7449000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	64200000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2023Q3	skin	Litigation Settlement Amount Awarded From Other Party Quarterly Payment Amount LitigationSettlementAmountAwardedFromOtherPartyQuarterlyPaymentAmount	100000	usd
CY2023Q3	skin	Number Of Quarterly Payments NumberOfQuarterlyPayments	13	payment
CY2023Q3	skin	Litigation Settlement Amount Awarded From Other Party Quarterly Payment Amount LitigationSettlementAmountAwardedFromOtherPartyQuarterlyPaymentAmount	100000	usd
CY2023Q3	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	1400000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	320000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	skin	Common Stock Voting Rights Votes CommonStockVotingRightsVotes	1	vote
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132569193	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132569193	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132214695	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132214695	shares
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4800000	usd
CY2022Q4	skin	Number Of Stock Repurchase Programs NumberOfStockRepurchasePrograms	2	program
CY2022Q3	skin	Number Of Stock Repurchase Programs NumberOfStockRepurchasePrograms	2	program
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-73818000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-81000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-90713000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	37691000	usd
CY2023Q3	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	0	usd
CY2022Q3	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	4284000	usd
	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	0	usd
	skin	Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount	71521000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-73818000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4365000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-90713000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-33830000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132896626	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150788695	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132679547	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150706795	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	629015	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1311451	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132896626	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151417710	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132679547	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152018246	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	600000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	298000000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	345400000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4700000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	152400000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	109656000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27648000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	783275000	usd
CY2022Q4	us-gaap	Assets Assets	1003083000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28467000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1429000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	71714000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	836030000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378751000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	167053000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1003083000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	27429000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	61363000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4353000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-902000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-81000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1717000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	85455000	usd
	us-gaap	Gross Profit GrossProfit	182288000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-23393000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	39561000	usd
	us-gaap	Net Income Loss NetIncomeLoss	37691000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32223000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Net Income Loss NetIncomeLoss	37691000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	72129000	usd
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001628280-23-038926-index-headers.html	Edgar Link	pending
0001628280-23-038926-index.html	Edgar Link	pending
0001628280-23-038926.txt	Edgar Link	pending
0001628280-23-038926-xbrl.zip	Edgar Link	pending
ex311-2023q310xq.htm	Edgar Link	pending
ex312-2023q310xq.htm	Edgar Link	pending
ex321-2023q310xq.htm	Edgar Link	pending
ex322-2023q310xq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
skin-20230930.htm	Edgar Link	pending
skin-20230930.xsd	Edgar Link	pending
skin-20230930_cal.xml	Edgar Link	unprocessable
skin-20230930_def.xml	Edgar Link	unprocessable
skin-20230930_pre.xml	Edgar Link	unprocessable
skin-20230930_lab.xml	Edgar Link	unprocessable
skin-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SKIN
Beauty Health Co Stock $skin

2023 Q4 Form 10-Q Financial Statement

#000162828023038926 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SKIN Beauty Health Co Stock $skin

2023 Q4 Form 10-Q Financial Statement

#000162828023038926 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SKIN
Beauty Health Co Stock $skin